stage iiic uterine corpus cancer

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage IIIA Uterine Corpus Cancer Trial in Canada,

Active, not recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +5 more
  • Baltimore, Maryland
  • +6 more
Apr 25, 2022

Endometrial Adenocarcinoma, Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer Trial in Bronx (drug, radiation,

Terminated
  • Endometrial Adenocarcinoma
  • +8 more
  • Bronx, New York
    Albert Einstein College of Medicine
Apr 21, 2021

Malignant Female Reproductive System Tumor, Malignant Hepatobiliary Tumor, Partner Trial in New Brunswick (Cognitive Behavior

Completed
  • Malignant Female Reproductive System Neoplasm
  • +38 more
  • Cognitive Behavior Therapy
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Apr 7, 2021

Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer, Stage II Uterine Corpus Cancer Trial in Bronx (Exercise

Completed
  • Stage IA Uterine Corpus Cancer
  • +7 more
  • Exercise Intervention
  • Bronx, New York
    Albert Einstein College of Medicine
Sep 13, 2019

Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,

Completed
  • Adult Hepatocellular Carcinoma
  • +44 more
  • Scottsdale, Arizona
  • +60 more
Jan 24, 2019

Stage I Breast Cancer, Stage I Cervical Cancer, Stage I Ovarian Cancer Trial in Philadelphia, Reading (Informational

Completed
  • Stage I Breast Cancer
  • +38 more
  • Informational Intervention
  • Philadelphia, Pennsylvania
  • +1 more
Feb 20, 2018

Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma Trial in United

Completed
  • Endometrial Adenosquamous Carcinoma
  • +10 more
  • Hartford, Connecticut
  • +8 more
Aug 23, 2017

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +64 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2016